Prostate biopsy in Tennessee: the highest-volume physicians
107 physicians in Tennessee billed Medicare for 3,495 prostate biopsy procedures in 2024. The top 25, with the year before beside it.
Top 25
| Rank | Physician | 2024 | 2023 | Change |
|---|---|---|---|---|
| 1 | Kristen R. Scarpato, MDUrology · Nashville | 135 | 146 | −8% |
| 2 | Adam B. Shrewsberry, MDUrology · Jefferson City | 124 | 134 | −7% |
| 3 | John M. Hassan, MDUrology · Franklin | 104 | 62 | +68% |
| 4 | Christopher E. Ramsey, MDUrology · Powell | 94 | 65 | +45% |
| 5 | Timothy J. Leroy, MDUrology · Knoxville | 90 | 57 | +58% |
| 6 | Christopher D. Maull, MDUrology · Oak Ridge | 85 | 31 | +174% |
| 7 | Jeffrey K. Mullins, MDUrology · Chattanooga | 79 | 64 | +23% |
| 8 | Ravi D. Chauhan, MDUrology · Germantown | 77 | 86 | −10% |
| 9 | Mark D. Greenberger, MDUrology · Memphis | 69 | 67 | +3% |
| 10 | Justin K. Kropf, MDUrology · Columbia | 61 | 59 | +3% |
| 11 | Christopher C. Hill, MDUrology · Nashville | 58 | 49 | +18% |
| 11 | Adam F. Stewart, MDUrology · Germantown | 58 | 50 | +16% |
| 11 | Walter Rayford, MD, PHD, FACSUrology · Memphis | 58 | 57 | +2% |
| 14 | Raymond C. Howard, MDUrology · Jackson | 55 | 29 | +90% |
| 14 | Lee Congleton, MDUrology · Powell | 55 | 57 | −4% |
| 16 | Chad M. Jackson, MDUrology · Murfreesboro | 53 | 45 | +18% |
| 16 | James M. Bienvenu, MDUrology · Knoxville | 53 | 50 | +6% |
| 18 | William V. Shappley, MDUrology · Germantown | 51 | 31 | +65% |
| 18 | Paul KnollUrology · Nashville | 51 | 19 | |
| 20 | Timothy C. Davenport, MDUrology · Jackson | 50 | 60 | −17% |
| 21 | Peter G. Lawrence, MDUrology · Jackson | 47 | 23 | +104% |
| 21 | Daniel Ramirez, MDUrology · Gallatin | 47 | 64 | −27% |
| 23 | Thomas B. Shelton, MDUrology · Germantown | 46 | 46 | +0% |
| 24 | Daniel Barocas, MDUrology · Nashville | 45 | 17 | |
| 25 | Benjamin L. Dehner, MDUrology · Nashville | 44 | 60 | −27% |
A rank counts procedures billed under the physician's own NPI (CPT 55700), in 2024, Medicare fee-for-service only. A surgeon who mostly treats younger or Medicare Advantage patients will rank lower than their total volume. Method and limits.